A directory of where to buy chemicals in the UK including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information.
| Product | Description | |
|---|---|---|
| Lu AE58054 HCl salt | Lu AE58054 hydrochloride is an in-vitro potency and selectivity, in-vivo binding affinity and effect of the 5-HT(6)R antagonist with a Ki value of 0.83 nM. Group: Pharmaceutical. CAS No. 467458-02-2. Pack Sizes: 50 mg. Product ID: B2693-462285. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Lubiprostone | Lubiprostone is a bicyclic fatty acid metabolite of Prostaglandin E1. It activates ClC-2 and CFTR chloride channels in the gastrointestinal tract, increasing intestinal fluid secretion. It is used in the management of idiopathic chronic constipation, and irritable bowel syndrome with constipation. Group: Pharmaceutical. CAS No. 136790-76-6. Pack Sizes: 100 mg. Product ID: B0084-057968. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lubiprostone Impurities | Lubiprostone Impurities, integral to analytical exploration within the biomedical realm, underpin research and development endeavors aimed at drug purity and efficacy assurance. Central to quality control operations for lubiprostone, these impurities validate therapeutic safety and effectiveness in treating chronic idiopathic constipation and irritable bowel syndrome with constipation, fortifying medicinal reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lubricants |  | |
| Lucidenic acid A | Lucidenic acid A, a naturally occurring compound found in Ganoderma lucidum fruiting bodies, displays immense therapeutic potential. It exhibits anti-inflammatory, anti-tumor, and anti-diabetic properties as evidenced by various studies. Additionally, it significantly impacts physiological parameters such as blood pressure, cholesterol, and blood sugar. The multifaceted activities of Lucidenic acid A render it an ideal candidate for treating chronic inflammatory diseases, diabetes, and cancer. Group: Pharmaceutical. CAS No. 95311-94-7. Pack Sizes: 20 mg. Product ID: B0005-465653. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid B | Lucidenic acid B, an organic compound hailing from Ganoderma lucidum, is praised for its multifaceted biomedical properties. From combating neoplasms to alleviating inflammations, this natural triterpenoid holds great promise in treating debilitating conditions such as breast and prostate cancers and an array of inflammatory disorders. Group: Pharmaceutical. CAS No. 95311-95-8. Pack Sizes: 10 mg. Product ID: B0005-465654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid C | Lucidenic acid C, an organic compound derived from the fungus Ganoderma lucidum, exhibits multifaceted pharmacological actions such as antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties. Novel studies have elucidated that this naturally occurring triterpene exhibits profound inhibition of malignancy development and metastasis in cancer cells. The promising therapeutic potential of lucidenic acid C extends beyond oncology, offering a plethora of therapeutic applications in diverse pathological conditions. Group: Pharmaceutical. CAS No. 95311-96-9. Pack Sizes: 10 mg. Product ID: B0005-465650. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid D | Lucidenic acid D, a triterpenoid compound, is extracted from Ganoderma lucidum and is reported to be endowed with multifarious biological activities, such as anti-cancer, anti-inflammatory, and antioxidant properties. With its remarkable potential to stimulate apoptosis in cancer cells, lucidenic acid D stands out as an effective therapeutic candidate for combating cancer and other ailments. Group: Pharmaceutical. CAS No. 98665-16-8. Pack Sizes: 10 mg. Product ID: NP7070. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid E | Lucidenic acid E, a triterpenoid derived from Ganoderma lucidum, exhibits potent anti-inflammatory, anti-tumor and anti-diabetic activities. Notably, it has demonstrated the ability to impede in vitro cancer cell growth, indicating its potential therapeutic value. Its hepatoprotective and antioxidant effects further increase the promise of lucidenic acid E in the treatment of liver ailments. Such multifaceted properties of this natural compound highlight its potential in the development of novel therapies. Group: Pharmaceutical. CAS No. 98665-17-9. Pack Sizes: 5 mg. Product ID: B0005-465651. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidenic acid LM1 | Lucidenic acid LM1, a triterpenoid compound, is obtained from medicinal fungi that are fit for consumption. Numerous biological activities have been ascertained to be associated with this compound such as anti-cancer, anti-inflammatory, and anti-fibrotic effects. The inhibition of human liver cancer and breast cancer cells are among the effects of Lucidenic acid LM1, which suggests its potential candidacy for the development of new anti-cancer drugs. Group: Pharmaceutical. CAS No. 364622-33-3. Pack Sizes: 10 mg. Product ID: B0005-465649. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucidin | Lucidin is a natural component of Rubia tinctorum L. It exhibits antibacterial activity. Group: Pharmaceutical. CAS No. 478-08-0. Pack Sizes: 100 mg. Product ID: B2703-119010. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lucyoside B | Lucyoside B is a triterpenoid compound found in the herbs of Luffa cylindrica ROEM. Group: Pharmaceutical. CAS No. 91174-19-5. Pack Sizes: 5 mg. Product ID: B0005-053511. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lufenuron | Lufenuron is a benzoylurea pesticide which inhibits the production of chitin in larval fleas. Group: Pharmaceutical. CAS No. 103055-07-8. Pack Sizes: 1 g. Product ID: BBF-05878. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lufenuron Impurities | Lufenuron Impurities, identified as trace elements during pharmaceutical synthesis, play a crucial role in quality control for antifungal and antiparasitic medications, particularly in combating flea infestations. These impurities provide significant insight into drug safety and efficacy, ensuring Lufenuron's optimal performance while enhancing the development of safer therapeutic alternatives. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luliconazole Impurities | Luliconazole Impurities are crucial analytical standards in the biomedical industry, predominantly utilized in the quality control and development of antifungal medications like luliconazole. These impurities facilitate the identification and quantification of trace components, ensuring drug safety and efficacy, particularly in treating dermatophytic infections such as athlete's foot and jock itch. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumacaftor | Lumacaftor is the second investigational oral candidate compound for the treatment of cystic fibrosis (CF). Lumacaftor may act to restore the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, the defective cell membrane protein responsible for the progression of CF. Lumacaftor defects in the CFTR protein affect the transport of chloride and other ions across cells, and lead to the accumulation of thick, sticky mucus in the lungs of patients with CF. This mucus fosters chronic infection and inflammation, and results in irreversible lung damage. Group: Pharmaceutical. CAS No. 936727-05-8. Pack Sizes: 250 mg. Product ID: B0084-079818. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumasiran | Lumasiran is a siRNA product that reduces hepatic oxalate production by targeting glycolate oxidase. By silencing the gene encoding glycolate oxidase, Lumasiran depletes glycolate oxidase and thereby inhibits the synthesis of oxalate, which is the toxic metabolite that is directly associated with the clinical manifestations of Primary hyperoxaluria type 1 (PH1). Group: Pharmaceutical. CAS No. 1834610-13-7. Pack Sizes: 5 mg. Product ID: B1370-072716. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumateperone | Lumateperone, also known as ITI-722 or ITI-007, is a highly potent 5HT2A antagonist for the treatment of sleep maintenance insomnia. Preclinical data has shown that ITI-722 is not sedating and should not exhibit next day hangover effects that are commonly associated with other sleep medications. Group: Pharmaceutical. CAS No. 313368-91-1. Pack Sizes: 50 mg. Product ID: B2693-470913. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumateperone Impurities | Lumateperone Impurities, serving as fundamental reference standards, hold a crucial position in the biomedical sector. They underpin formulation and quality assurance processes for the antipsychotic Lumateperone, facilitating pharmacokinetic analyses. Their role is vital in safeguarding drug safety and effectiveness, particularly in addressing schizophrenia and bipolar disorder through meticulous contaminant identification and quantification. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumateperone Tosylate | The tosylate salt form of Lumateperone which is an highly effective antagonist of 5-HT2A receptor, could be used against insomnia. IC50: 0.54 nM(Ki). Uses: The tosylate salt form of lumateperone which is an highly effective antagonist of 5-ht2a receptor and could be used against insomnia. Group: Pharmaceutical. CAS No. 1187020-80-9. Pack Sizes: 200 mg. Product ID: B2693-474376. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumefantrine Impurities | Lumefantrine Impurities are critical components in the quality control and development of antimalarial drugs. They are primarily studied to ensure the efficacy and safety of lumefantrine, a key agent in treating malaria. Understanding these impurities aids in optimizing drug formulations for improved therapeutic outcomes against Plasmodium infections. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luminespib | Luminespib, also known as AUY-922 (or NVP-AUY922), is a derivative of 4,5-diarylisoxazole and a third-generation heat shock protein 90 (Hsp90) inhibitor with potential antineoplastic activity. Hsp90 inhibitor AUY922 has been shown to bind with high affinity to and inhibit Hsp90, resulting in the proteasomal degradation of oncogenic client proteins. Group: Pharmaceutical. CAS No. 747412-49-3. Pack Sizes: 50 mg. Product ID: B0084-251226. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luminol | Luminol Uses: Pharmaceutical Research and Development. Group: Intermediates. CAS No. 521-31-3. Pack Sizes: Enquire for MOQ. Categories: NORDMANN UK Fine Chemicals: innovative sourcing and supply. |  UK / EU / USA / Japan |
| LUMINOL (3-AMINOPTHALHYDRAZIDE) UN | LUMINOL (3-AMINOPTHALHYDRAZIDE) UN, UK suppliers of laboratory chemicals and apparatus needed |  |
| Luminol sodium salt | Luminol sodium salt is a reagent used in chemiluminescence analysis of metal cations, blood and glucococorticoids. Group: Pharmaceutical. CAS No. 20666-12-0. Pack Sizes: 100 g. Product ID: B1370-366297. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lumiracoxib Impurities | Lumiracoxib Impurities, integral in pharmacological examinations, act as essential analytical markers, facilitating meticulous calibration and stringent evaluation of drug integrity and therapeutic efficacy in osteoarthritis and rheumatoid maladies. By aiding in degradation entity identification, they ensure the safety and effectiveness of lumiracoxib, a selective COX-2 inhibitor, in clinical applications. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lunasin | Lunasin is a novel, cancer-preventive peptide whose efficacy against chemical carcinogens and oncogenes has been demonstrated in mammalian cells and in a skin cancer mouse model. Group: Pharmaceutical. Pack Sizes: 1 mg. Product ID: BAT-006145. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lup-20(29)-en-28-oic acid, 3-[ D-glucopyranosyl(1?4)[ L-rhamnopyranosyl) (1?2)-L-arabinopyranosyl]oxy], (3,4)-) | Lup-20(29)-en-28-oic acid, 3-[ D-glucopyranosyl(1→4)[ L-rhamnopyranosyl) (1→2)-L-arabinopyranosyl]oxy], (3,4)-) is extracted from Pulsatilla chinensis (Bunge) Regel. Group: Pharmaceutical. CAS No. 848784-87-2. Pack Sizes: 5 mg. Product ID: B0005-465772. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lup-20(29)-ene-3α,23-diol | Lup-20(29)-ene-3α,23-diol isolated from the barks of Glochidion macrophyllum. Uses: Anti-hiv activity. Group: Pharmaceutical. CAS No. 32451-85-7. Pack Sizes: 1 mg. Product ID: NP6606. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lupenone | Lupenone is isolated from the roots of Pueraria thomsonii Benth. It effectively inhibited adipocyte differentiation through downregulating the related transcription factor, particularly the PPARγ gene. Group: Pharmaceutical. CAS No. 1617-70-5. Pack Sizes: 25 mg. Product ID: NP6327. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lupeol | Lupeol is isolated from the flower of Chrysanthemum morifolium. It enhances the radiosensitivity of SMMC-7721 cells in vitro and in vivo. Uses: Anti-inflammatory agents. Group: Pharmaceutical. CAS No. 545-47-1. Pack Sizes: 250 mg. Product ID: NP7233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luperox A75 | Luperox A75. Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 94-36-0. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. |  Cenik Chemicals |
| Lurbinectedin | Lurbinectedin, also known as PM01183, is a synthetic tetrahydropyrrolo [4, 3, 2-de]quinolin-8(1H)-one alkaloid analogue with potential antineoplastic activity. DNA minor groove-binding agent PM01183 covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death. Group: Pharmaceutical. CAS No. 497871-47-3. Pack Sizes: 1 mg. Product ID: B2693-462566. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lusutrombopag | Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist. It acts selectively on the human TPO receptor and activates signal transduction pathways and thereby increases platelet levels. It was developed by Shionogi for chronic liver disease (CLD) patients with thrombocytopenia prior to elective invasive surgery. It has been listed. Uses: Lusutrombopag was used for chronic liver disease (cld) patients with thrombocytopenia prior to elective invasive surgery. Group: Pharmaceutical. CAS No. 1110766-97-6. Pack Sizes: 300 mg. Product ID: B0084-475066. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lutein | Lutein is a xanthophyll isolated from the herbs of Tagetes erecta. It is isomeric with zeaxanthin thus has similar properties as zeaxanthin. Lutein exhibits antioxidant, antimutagenic and anti-tumor effects, and has the potential to treat macular degeneration. Lutein can be used in food additive. Lutein has antioxidant activity, which can protect skin cells well, make skin cells resist oxidation from the very beginning, stay away from the harm of free radicals, play a strong role in whitening, freckling, wrinkling, moisturizing, increasing skin elasticity, improve skin luster and smoothness, and delay skin aging. Uses: Ingredient of health care products. Group: Pharmaceutical. CAS No. 127-40-2. Pack Sizes: 25 mg. Product ID: BBF-05800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin | 5g Pack Size. Group: Aroma Chemicals, Biochemicals. Formula: C15H10O6. CAS No. 491-70-3. Prepack ID : 54514003-5g. Molecular Weight : 286.24. |  |
| Luteolin | Luteolin is an anti-inflammatory, antioxidant and free radical scavenger. Luteolin inhibits LPS-induced TNF-α, IL-6 and inducible nitric oxide production and blocks NF-κB and AP-1 activation. It also inhibits TNF-α-induced COX-2 expression, and phosphodiesterase with with Ki of 15.0 μM, 6.4 μM, 13.9 μM, 11.1 μM and 9.5 μM for PDE1-5 respectively. It inhibits proliferation of Lewis lung carcinoma cells in vivo. Luteolin is a natural compound found in the leaves of Dracocephalum ruyschiana L. It can be used in cosmetics material. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 491-70-3. Pack Sizes: 5 g. Product ID: NP1855. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin-3-O-beta-D-glucuronide | Luteolin-3-O-beta-D-glucuronide is a flavonoid isolated from Rosmarinus officinalis. Group: Pharmaceutical. CAS No. 53527-42-7. Pack Sizes: 10 mg. Product ID: B2703-334466. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin 5-methyl ether | Luteolin 5-methyl ether, a flavone compound of natural origin with potent pharmacological effects, can be obtained from a variety of plant species. Its therapeutic potential encompasses a broad spectrum of health conditions such as cancer, cardiovascular diseases, diabetes, and neurodegenerative disorders, primarily due to its antioxidant, anti-inflammatory, and antitumor properties. The inspiring results from studies conducted in this realm suggest that Luteolin 5-methyl ether is a promising candidate for the development of novel therapeutic agents. Group: Pharmaceutical. CAS No. 58115-29-0. Pack Sizes: 1 mg. Product ID: NP2182. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin 7-O-glucoside | Cynaroside is a flavone, a flavonoid-like chemical compound. It is a 7-O-glucoside of luteolin. Group: Pharmaceutical. CAS No. 5373-11-5. Pack Sizes: 100 mg. Product ID: NP1883. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteolin-7-O-neohesperidoside | Luteolin-7-O-neohesperidoside is a flavone found in Veronicastrum sibiricum var. japonicum and in Teucrium gnaphalodes. Group: Pharmaceutical. CAS No. 25694-72-8. Pack Sizes: 10 mg. Product ID: B2703-003309. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luteone | Luteone is a natural flavonoid isolated from the herbs of Erythrina variegata Linn. Group: Pharmaceutical. CAS No. 41743-56-0. Pack Sizes: 1 mg. Product ID: NP2140. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luvangetin | Luvangetin is a coumarin isolated from the stem bark of Zanthoxylum ailanthoides. Luvangetin exhibits inhibition against superoxide anion (O2 -) generation and elastase release by human neutrophils in response to fMLP/CB. Group: Pharmaceutical. CAS No. 483-92-1. Pack Sizes: 5 mg. Product ID: NP1044. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Luxabendazole Impurities | Luxabendazole Impurities, integral to anthelmintic pharmacological research, are scrutinized for their role in enhancing treatment efficacy against helminthic afflictions. Their assessment focuses on the safety, stability, and pharmacodynamics of Luxabendazole, providing critical insights that underpin advancements in nematode infection therapies, ultimately elevating treatment paradigms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Valacyclovir Hydrochloride | Valaciclovir HCl is an antiviral drug used in the management of herpes simplex, herpes zoster, and herpes B. Group: Pharmaceutical. CAS No. 124832-27-5. Pack Sizes: 100 g. Product ID: B2693-082659. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Valine | 500g Pack Size. Group: Amino Acids, Biochemicals, Peptide Reagents. Formula: C5H11NO2. CAS No. 72-18-4. Prepack ID : 11273495-500g. Molecular Weight : 117.15. | |
| L-Valine | 100g Pack Size. Group: Amino Acids, Biochemicals, Peptide Reagents. Formula: C5H11NO2. CAS No. 72-18-4. Prepack ID : 11273495-100g. Molecular Weight : 117.15. | |
| L-VALINE UN | L-VALINE UN, UK suppliers of laboratory chemicals and apparatus needed | |
| Lvguidingan | Lvguidingan is an antiepileptic drug. Group: Pharmaceutical. CAS No. 82351-05-1. Pack Sizes: 50 mg. Product ID: B0084-284835. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Vinylglycine | L-Vinylglycine is a non-proteinogenic L-alpha-amino acid and an inhibitor of aspartate aminotransferase. Group: Pharmaceutical. CAS No. 70982-53-5. Pack Sizes: 100 mg. Product ID: B0084-335459. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LX-4211 | LX-4211 is a potent dual SGLT2/1 inhibitor; Antidiabetic agents. Uses: Sodium-glucose transporter 2 inhibitors. Group: Pharmaceutical. CAS No. 1018899-04-1. Pack Sizes: 50 mg. Product ID: B0084-463492. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Lx7101 Impurities | Lx7101 Impurities are vital in the biomedical field for assessing the purity and efficacy of Lx7101, an inhibitor targeting ocular diseases like glaucoma. These impurities help refine analytical methods, ensuring therapeutic effectiveness and safety, thereby facilitating advanced pharmaceutical research and development in ophthalmology. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| L-Xylulose | L-Xylulose, an organic sugar alcohol, finds significant utility within the dynamic biomedicine sector as a crucial carbohydrate source and an intermediary compound in the synthesis of pharmaceuticals and biochemicals. Group: Pharmaceutical. CAS No. 527-50-4. Pack Sizes: 50 mg. Product ID: B2705-122241. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2109761 | LY2109761 is a novel inhibitor of TGF-β receptor type I/type II kinases (IC50 = 69 nM), displaying antitumor activity. In vivo study demonstrated that LY2109761, in combination with gemcitabine, significantly reduced the tumor burden, prolonged survival, and reduced spontaneous abdominal metastases. Group: Pharmaceutical. CAS No. 700874-71-1. Pack Sizes: 100 mg. Product ID: B2693-286403. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2228820 dimesylate | LY2228820 dimesylate is the salt form of LY2228820, a tri-substituted imidazole derivative and p38α and β MAPK inhibitor. LY2228820 inhibits tumor growth in various cancer models. Group: Pharmaceutical. CAS No. 862507-23-1. Pack Sizes: 10 mg. Product ID: B0084-286454. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2456302 | LY-2456302, also called as CERC-501, is a potent, highly selective and centrally-penetrant kappa opioid receptor antagonist (Ki = 0.807 nM) with favorable pharmacokinetic and pharmacodynamic properties to evaluate the role of KOR in preclinical models of alcoholism. Group: Pharmaceutical. CAS No. 1174130-61-0. Pack Sizes: 100 mg. Product ID: B2693-007347. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2510924 | LY-2510924 is an inhibitor of CXC chemokine receptor 4 (CXCR4). It has potential antineoplastic activity. It binds to the chemokine receptor CXCR4, thereby preventing CXCR4 binding to its ligand, stromal derived factor-1 (SDF-1), and subsequent receptor activation upon subcutaneous administration, which may result in decreased tumor cell proliferation and migration. It plays an important role in chemotaxis and angiogenesis and is upregulated in several tumor cell types. Uses: Ly-2510924 has potential antineoplastic activity. it plays an important role in chemotaxis and angiogenesis. Group: Pharmaceutical. CAS No. 1088715-84-7. Pack Sizes: 5 mg. Product ID: BAT-006091. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-2562175 | LY2562175 is a potent and selective FXR agonist in vitro. It has robust lipid modulating properties, lowering LDL and triglycerides while raising HDL in preclinical species. It was developed by Eli Lilly and Company and in clinic phase 1 trials with no progress. Uses: Ly2562175 has robust lipid modulating properties, lowering ldl and triglycerides while raising hdl in preclinical species. Group: Pharmaceutical. CAS No. 1103500-20-4. Pack Sizes: 10 mg. Product ID: B2693-475063. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2606368 | LY2606368 is a potent and selective ATP competitive inhibitor(IC50=1.5 nM in SW1990 cell) of the Chk1 protein kinase. Group: Pharmaceutical. CAS No. 1234015-52-1. Pack Sizes: 10 mg. Product ID: B0084-462722. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2784544 | LY2784544 is a potent and selective JAK2 inhibitor (IC50 = 3 nM), and exhibits less potency against JAK3 (IC50 =48 nM). LY2784544 effectively inhibits JAK2V617F-driven signaling and cell proliferation in Ba/F3 cells (IC50 = 20 and 55 nM, respectively). It reduces JAK2V617F tumor cell burden with no effect on erythroid progenitor cells. Group: Pharmaceutical. CAS No. 1229236-86-5. Pack Sizes: 25 mg. Product ID: B0084-286443. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY2795050 | LY2795050, a κ-opioid Receptor antagonist, has been found to be effective in imaging KOR behaving as a PET tracer. IC50: 0.72 nM and 25.8 nM for κ-opioid Receptor and κ-opioid. Uses: Ly2795050 is a κ-opioid receptor antagonist that has been found to be effective in imaging kor behaving as a pet tracer. Group: Pharmaceutical. CAS No. 1346133-08-1. Pack Sizes: 10 mg. Product ID: B0084-474497. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY294002 | LY294002 is a potent inhibitor of phosphoinositide PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM, respectively. Group: Pharmaceutical. CAS No. 154447-36-6. Pack Sizes: 300 mg. Product ID: B0084-084812. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY3009120 | LY03009120 is a potent pan-Raf inhibitor with IC50 of 44 nM, 31-47 nM, and 42 nM for A-raf, B-Raf, and C-Raf in A375 cells, respectively. Phase 1. Group: Pharmaceutical. CAS No. 1454682-72-4. Pack Sizes: 100 mg. Product ID: B2693-470864. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-364947 | LY364947 is a selective inhibitor of TGF-β type-I receptor with potential anticancer activity. LY364947 inhibits TGF-β-dependent luciferase production in mink lung cells (p3TP lux) and growth in mouse fibroblasts (NIH 3T3). Uses: Reprogramming. Group: Pharmaceutical. CAS No. 396129-53-6. Pack Sizes: 100 mg. Product ID: B1370-353667. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY404039 | LY-404,039, also known as pomaglumetad, is an amino acid analog drug that acts as a highly selective agonist for the metabotropic glutamate receptor group II subtypes mGluR2 and mGluR3. Group: Pharmaceutical. CAS No. 635318-11-5. Pack Sizes: 50 mg. Product ID: B0084-146172. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-411575 | LY-411575, also known as LSN-411575, is a potent, cell-permeable γ-secretase inhibitor (IC50 = 0.078 nM/0.082 nM in membrane-assay/in cell-basedγ-secretase assays) and also inhibits Notch clevage (IC50 = 0.39 nM). Group: Pharmaceutical. CAS No. 209984-57-6. Pack Sizes: 25 mg. Product ID: B0084-087322. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LY-900009 | LY-900009 is a small-molecule inhibitor of Notch signalling with IC50 value of 0.27 nM via selective inhibition of the γ-secretase protein. LY-900009 was developed as a candidate therapeutic drug against AD (IDENTITY trial), which failed in phase III trials. Uses: Gamma secretase inhibitors and modulators. Group: Pharmaceutical. CAS No. 209984-68-9. Pack Sizes: 10 mg. Product ID: B0084-475540. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| LYCHEE | LYCHEE - Our signature range of liquid botanical extracts |  England, Scotland |
| LYCHEE SEED | Product Name: LYCHEE SEED. Form: Ground. INCI Monograph: LITCHI CHINENSIS SEED POWDER. Ingredient Source: Plant. Brown Granules. Natural Exfoliants | England, Scotland |
| Lycobetaine | Lycobetaine is a remarkable biomedical innovation engineered to efficaciously study intricate cardiovascular maladies. Harnessing the invaluable attributes derived from bountiful bionatural origins, Lycobetaine proficiently merges indispensable nutritive constituents with potent antioxidants. Group: Pharmaceutical. CAS No. 72510-04-4. Pack Sizes: 10 mg. Product ID: B2703-465576. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
